Children with Cancer, Fever, and Treatment-Induced Neutropenia: Risk Factors Associated with Illness Requiring the Administration of Critical Care Therapies

Pediatric Emergency Care

Volumn 20, Issue 2, 2004, Pages 79-84

  West, Daniel C ^a,b   Marcin, James P ^a   Mawis, Roland ^a   He, Jingsong ^a   Nagle, Audrey ^a   Dimand, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Critical illness; Fever and neutropenia; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; FEVER; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; NEUTROPENIA; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; FEVER; HUMANS; INFANT; LOGISTIC MODELS; NEOPLASMS; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 1242271366     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000113875.10140.40     Document Type: Article

References (19)

1. Pizzo PA, Robichaud KJ, Wesley R, et al. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine (Baltimore). 1982;61(3):153-165.
2. Rackoff WR, Gonin R, Robinson C, et al. Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol. 1996; 14(3):919-924.
3. Klaassen RJ, Goodman TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18(5):1012-1019.
4. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18(16):3038-3051.
5. Kern WV, Cometta A, De Bock R, et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med. 1999;341(5):312-318.
6. Freifeld A, Marchigiani D, Walsh T, et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med. 1999;341(5):305-311.
7. Aquino VM, Tkaczewski I, Buchanan GR. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis. 1997;25(1):74-78.
8. Mullen CA, Petropoulos D, Roberts WM, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer. 1999;86(1):126-134.
9. Aquino VM, Buchanan GR, Tkaczewski I, et al. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. Med Pediatr Oncol. 1997;28(3):191-195.
10. Talcott JA, Siegel RD, Finberg R, et al. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol. 1992;10(2):316-322.
11. Bates DW, Cook EF, Goldman L, et al. Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med. 1990;113(7):495-500.
12. Lowrey GH. Growth and Development of Children. Chicago: Year Book Medical Publishers; 1986.
13. Chen CH, George SL. The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. Stat Med. 1985;4(1):39-46.
14. Mullen CA, Buchanan GR. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. J Clin Oncol. 1990;8(12):1998-2004.
15. Jones GR, Konsler GK, Dunaway RP, et al. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol. 1996;13(3):217-229.
16. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19 (14):3415-3421.
17. Lucas KG, Brown AE, Armstrong D, et al. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer. 1996;77(4):791-798.
18. Quadri TL, Brown AE. Infectious complications in the critically ill patient with cancer. Semin Oncol. 2000;27(3):335-346.
19. Castagnola E, Paola D, Giacchino R, et al. Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: a literature review. J Hematother Stem Cell Res. 2000;9(5):645-649.